SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is drawing significant investor attention due to recent conservative 2026 revenue guidance and uncertainty surrounding DefenCath's post-TDAPA reimbursement, fueling widespread frustration despite a new $75 million share repurchase program. The community is actively discussing potential legislative fixes and upcoming pipeline catalysts like Rezzayo's Phase 3 data, while scrutinizing management's actions amid the stock's pronounced decline.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a high-stakes bidding war for Warner Bros. Discovery, intensified by a widening DOJ antitrust probe and political threats; the community is actively debating whether walking away with a breakup fee or proceeding with the acquisition would be a better outcome for the streaming giant.

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.

Caris Life Sciences Inc.

Caris Life Sciences is trending as the market digests strong preliminary 2025 revenue guidance and its first quarter of positive adjusted EBITDA and cash flow from operations, fueling debate among investors over whether this AI-powered precision oncology firm is an undervalued gem or facing headwinds from valuation concerns and an upcoming IPO lockup expiration.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery is actively trending as its board reconsiders a sweetened hostile takeover bid from Paramount Skydance, fueled by Netflix's temporary waiver and intensified DOJ scrutiny of Netflix's original offer. The community is debating which path offers better shareholder value and a clearer regulatory approval amidst the fierce media industry consolidation.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending following its recent listing on Robinhood, with fervent community discussion centered on its potential as Coinbase's premier perpetual decentralized exchange on the #base app. While supporters highlight its significant undervaluation compared to rivals and strong platform backing, a vocal segment raises concerns about its past performance, tokenomics, and leadership, labeling it a 'scam' or 'rug pull'.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid escalating speculation of a potential buyout from major tech players, fueled by its uniquely valuable n53 spectrum and deepening Apple partnership for advanced iPhone satellite connectivity. The community eagerly anticipates key FCC decisions regarding spectrum use and the deployment of its C-3 constellation, which are seen as critical catalysts for unlocking the company's significant underlying value and expanding its private network and IoT solutions.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BridgeBio Pharma is currently trending due to a series of overwhelmingly positive Phase 3 clinical trial results, including a breakthrough oral treatment for achondroplasia that is seen as a major competitive advancement. This strong pipeline performance, coupled with robust Attruby sales and significant analyst upgrades, has ignited community excitement about the company's rapid evolution into a leading multi-product rare disease biotech.

Progressive Corp. is an insurance holding company, which engages in the provision of personal and commercial auto insurance, residential property insurance, and other specialty property-casualty insurance and related services. It operates through the following segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment includes agency and direct businesses. The Commercial Lines segment writes primary liability and physical damage insurance for automobiles and trucks owned and operated predominately by small business in the auto, for-hire transportation, contractor, for-hire specialty, tow, and for-hire livery markets. The Property segment covers residential property insurance for homeowners, other property owners, and renters. The company was founded on March 10, 1937, and is headquartered in Mayfield Village, OH.

Progressive Corp.

Progressive Corp

Progressive is a trending topic amidst mixed reactions to its recent financial reports, which show strong premium and investment income growth alongside fluctuating combined ratios, prompting widespread customer discussion around rising rates. The community is actively debating if its valuation is justified by its tech-driven underwriting and potential AI leadership, or if customer dissatisfaction and market dynamics present challenges within the insurance sector.

Sonos, Inc. engages in the provision of multi-room wireless audio products. It supports streaming services and provides access to music, Internet radio, podcasts, and audiobooks, with control from Android smartphones, iPhone or iPad. The company was founded by Mai Trung, John MacFarlane, Craig A. Shelburne, and Thomas S. Cullen in 2002 and is headquartered in Santa Barbara, CA.

Sonos Inc

Sonos is trending after reporting a stronger-than-expected fiscal Q1 earnings beat, with expanding margins and cash flow signaling progress toward profitability. The community is actively discussing whether this marks a real inflection point for the premium audio company, as management emphasizes future product innovations to drive fiscal 2026 growth.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending as recent preliminary benchmarks for its Gemini-II Compute-in-Memory chip claim competitive multimodal LLM inference at the edge with significantly lower power consumption than rivals. This news is sparking intense debate among investors, with bulls highlighting the chip's potential for defense and drone applications and institutional interest, while critics vehemently allege fraudulent performance claims and an ongoing class-action investigation regarding misleading statements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to Hold

Wall Street Zen upgraded shares of Immatics from a "sell" rating to a "hold" rating in a research report on Saturday...

Immatics (NASDAQ:IMTX) Shares Down 5% - Time to Sell?

Immatics (NASDAQ:IMTX) Stock Price Down 5% - What's Next...

Wall Street Zen Downgrades Immatics (NASDAQ:IMTX) to Sell

Wall Street Zen downgraded shares of Immatics from a "hold" rating to a "sell" rating in a research report on Sunday...

Immatics (NASDAQ:IMTX) Stock Price Down 8.8% - What's Next?

Immatics (NASDAQ:IMTX) Stock Price Down 8.8% - Here's What Happened...

Immatics (NASDAQ:IMTX) Upgraded at Wall Street Zen

Wall Street Zen raised Immatics from a "sell" rating to a "hold" rating in a research report on Saturday...

Immatics (NASDAQ:IMTX) Trading Up 3.9% - Time to Buy?

Immatics (NASDAQ:IMTX) Shares Up 3.9% - Still a Buy...

Immatics N.V. (NASDAQ:IMTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Immatics N.V. (NASDAQ:IMTX - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are covering the stock, MarketBeat.com reports. One analyst...

Immatics (NASDAQ:IMTX) Trading Up 8.9% - Time to Buy?

Immatics (NASDAQ:IMTX) Trading 8.9% Higher - Here's What Happened...

Immatics (NASDAQ:IMTX) Sets New 12-Month High - Here's What Happened

Immatics (NASDAQ:IMTX) Sets New 1-Year High - What's Next...

Chardan Capital Reaffirms Buy Rating for Immatics (NASDAQ:IMTX)

Chardan Capital reaffirmed a "buy" rating and set a $25.00 price target on shares of Immatics in a research note on Monday...

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.

Current Price	$10.06
Prev Close	$10.30
Open	$10.09
Dividend Yield	0.00%
50-Day Moving Average	$9.89
Beta	1.20
Avg. Volume	385,894.85
PE Ratio	-9.20

52-Week High	$12.41
52-Week Low	$3.30
Market Capitalization	$1.35B
EPS (Annual)	$0.1557
Price to Book	2.50
Revenue Per Employee	$398,499.48

IMTX
Immatics N.V

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMTX News

IMTXImmatics N.V